HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukotrienes and airway inflammation.

AbstractBACKGROUND:
Asthma is a common chronic inflammatory disease of the airways characterized by airway obstruction and hyperresponsiveness. Leukotrienes (LTs) are lipid mediators that contribute to many aspects of asthma pathogenesis. As the LT pathway is relatively steroid-resistant, its blockade by alternative strategies is a desirable component of asthma management. Cysteinyl LT (cysLT) receptor 1 antagonists (LTRAs) have been utilized worldwide for more than 10years, and while their efficacy in asthma is well accepted, their limitations are also evident.
SCOPE OF REVIEW:
In this review, we summarize the biological effects of LTs in asthma, review recent advances in LT receptors, and consider possible new therapeutic targets in the LT pathway that offer the potential to achieve better control of asthma in the future.
MAJOR CONCLUSIONS:
CysLTs play pathogenetic roles in many aspects of asthma, and blockade of cysLT receptor 1 by currently available LTRAs is certainly beneficial in disease management. On the other hand, the limitations of LTRAs are also apparent. Recent studies have revealed new receptors for cysLTs other than classical cysLT receptors 1 and 2, as well as the potential importance of LTB(4) in asthma.
GENERAL SIGNIFICANCE:
Recent findings provide clues to new approaches for targeting the LT pathway that may overcome the current limitations of LTRAs and achieve superior control of asthma. This article is part of a Special Issue entitled: Biochemistry of Asthma.
AuthorsKatsuhide Okunishi, Marc Peters-Golden
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1810 Issue 11 Pg. 1096-102 (Nov 2011) ISSN: 0006-3002 [Print] Netherlands
PMID21352897 (Publication Type: Journal Article, Review)
Copyright2011 Elsevier B.V. All rights reserved.
Chemical References
  • Leukotriene Antagonists
  • Leukotrienes
Topics
  • Animals
  • Asthma (drug therapy, etiology)
  • Humans
  • Leukotriene Antagonists (therapeutic use)
  • Leukotrienes (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: